Collects public and private clinical studies of human volunteers in about 200 countries. ClinicalTrials.gov contains data self-reported by trial sponsors or investigators by means of a Web-based system. The database provides information about studies protocols and also some informations about the study results.
Gathers clinical trials about amyotrophic lateral sclerosis (ALS). PRO-ACT is a public database which compiles datasets from industry and academic clinical trials according to a comprehensive common data structure with the aim of easing research about ALS. It includes more than 10700 demographics data and over 68000 longitudinal information on revised ALS Functional Rating Scale (ALSFRS(-R). Information about vital capacity, vital signs, safety labs, concomitant medications and adverse events are also provided.
Works on making clinical trial data from the FDA (US Food and Drug Administration) more easily accessible and searchable. OpenTrialsFDA extracts the relevant data from the FDA documents, link it to other clinical trial data and present it through this new user-friendly web interface. Through the OpenTrialsFDA interface, users are able to explore and discover the FDA data. In addition, the information has been integrated into the OpenTrials database, so that the FDA report can be linked to reports from other sources, such as ClinicalTrials.gov, EU CTR, HRA, WHO ICTRP, and PubMed.
Shares human subjects data from all clinical trials funded by the National Institute of Mental Health. NDCT was created by the NIMH, it supports additional mental health-related clinical trial communities by accepting and sharing this data regardless of funding source. Qualified researchers can request access to shared data, as well as the other repositories that make up the NIMH Data Archive. The user can view summary-level data, or can request access to query and download subject-level data.
Provides access to scientific and clinical information related to the use of keyhole limpet hemocyanin (KLH). KLH Site is a database that includes links to biomedical literature, breaking news of new vaccine development, and information on KLH biochemistry and use.
Provides a biospecimen inventory and bioinformatics infrastructure to enable research to advance the clinical management of genetically triggered thoracic aortic aneurysms (TAAs) and related complications. GenTAC is a longitudinal observational cohort study enrolling patients with conditions related to genetically-induced TAAs from five regional clinical centers in the United States. It has been established to facilitate studies by GenTAC investigators and others.